Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Sales | 459,074 | 379,268 | 238,457 | 125,024 | 63,447 |
| Cost of Goods | 2,093 | 1,686 | 923 | N/A | 8,146 |
| Gross Profit | 456,981 | 377,582 | 237,534 | 125,024 | 55,301 |
| Operating Expenses | 554,546 | 452,371 | 324,706 | 240,397 | 163,102 |
| Operating Income | -97,472 | -74,103 | -86,249 | -115,373 | -107,655 |
| Interest Expense | 9,118 | 2,337 | 7,752 | 12,043 | 12,043 |
| Other Income | 2,122 | 4,488 | 17,223 | 20,897 | 16,548 |
| Pre-tax Income | -104,468 | -71,952 | -76,778 | -106,519 | -103,150 |
| Income Tax | N/A | -4,122 | 2,351 | N/A | N/A |
| Net Income Continuous | -104,468 | -67,830 | -79,129 | -106,519 | -103,150 |
| Net Income | $-104,468 | $-67,830 | $-79,129 | $-106,519 | $-102,337 |
| EPS Basic Total Ops | -1.26 | -0.85 | -1.00 | -1.61 | -1.77 |
| EPS Basic Continuous Ops | -1.26 | -0.85 | -1.00 | -1.61 | -1.78 |
| EPS Diluted Total Ops | -1.26 | -0.85 | -1.00 | -1.61 | -1.77 |
| EPS Diluted Continuous Ops | -1.26 | -0.85 | -1.00 | -1.61 | -1.78 |
| EBITDA(a) | $-77,785 | $-59,856 | $-74,962 | $-103,886 | $-93,063 |